Summary

Retinal Imaging Devices Market Growth & Trends

The global retinal imaging devices market size is expected to reach USD 6.35 billion by 2030, registering a CAGR of 7.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors. One of the primary market drivers is the increasing prevalence of retinal disorders, such as diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma. These conditions are becoming more common due to an aging population and a rise in lifestyle-related diseases like diabetes and hypertension, which have direct implications for eye health. As a result, there is a growing demand for advanced diagnostic tools that can detect these disorders early and accurately, leading to better patient outcomes and more effective management of eye health.

Technological advancements are playing a crucial role in the expansion of the market. Innovations such as optical coherence tomography (OCT), fundus photography, and the integration of artificial intelligence (AI) for automated image analysis are significantly enhancing the accuracy and efficiency of retinal imaging. For instance, Nikon’s UWF retinal imaging technology launch in March 2022 dramatically boosts Japan’s market. This UWF imaging captures up to 200 degrees of the retina in one image, enhancing the detection and management of retinal diseases such as diabetic retinopathy and AMD. It meets the growing demand for advanced diagnostic tools driven by Japan’s aging population. These technologies enable earlier and more precise diagnosis of retinal disorders, which is essential for preventing vision loss. AI-driven solutions, in particular, are transforming the field by providing ophthalmologists with sophisticated tools for analyzing complex retinal images, thereby facilitating more informed decision-making and personalized treatment plans.

The competitive landscape in the market is characterized by the presence of several major players. These companies are actively enhancing their product portfolios through strategies such as continuous product upgrades to incorporate the latest technological advancements, strategic collaborations, and exploring opportunities for acquisitions. Obtaining government approvals for their products is also crucial to ensure compliance with regulatory standards, which can enhance product credibility and facilitate market entry.

Government initiatives and programs are significantly contributing to the growth of the market. Many governments are investing in public health campaigns and screening programs to promote the early detection and management of eye diseases. Such initiatives not only increase awareness about the importance of regular eye exams but also drive demand for advanced retinal imaging technologies. Additionally, favorable regulatory frameworks and policies that support innovation and investment in healthcare infrastructure are creating a conducive environment for market growth. These efforts are essential in ensuring that cutting-edge retinal imaging devices are accessible to a broader population, ultimately improving eye health outcomes on a global scale.

Some of the key players in the market are Carl Zeiss Meditec AG, Topcon Corporation, NIDEK Co., Ltd., Heidelberg Engineering GmbH, Optos Plc (a Nikon Company), Canon Inc., Alcon Inc., Bausch + Lomb (a division of Bausch Health Companies Inc.), Optovue, Inc., Essilor International, and Olympus Vision. In April 2024, the company announced that the Optomed Aurora handheld fundus camera, equipped with AEYE’s AI, received FDA clearance. These players are involved in various strategic initiatives such as product launch and approval in order to cater to a global clientele.

Retinal Imaging Devices Market Report Highlights

• Based on device, Optical Coherence Tomography (OCT) devices accounted for largest revenue share of 28.9% in 2023. Optical Coherence Tomography (OCT) is a noninvasive imaging technology used to obtain high-resolution cross-sectional images of biological tissues. OCT has become a critical tool in ophthalmology, enabling detailed visualization of the retina's layers and aiding in the diagnosis & management of various eye conditions, such as macular degeneration, Diabetic Retinopathy (DR), and glaucoma.

• Based on application, disease diagnosis dominated the market and accounted for the largest share of 53.9% in 2023.The increasing prevalence of retinal diseases, such as DR and AMD, is a significant driver for the disease diagnosis segment of the market.

• Based on indications, Diabetic retinopathy segment is dominated the indication segments with the largest market share of 32.1% in 2023. As increasing global prevalence of diabetic retinopathy increases, need for advanced diagnostic and monitoring technologies surges contributing to the segments high market share.

• Based on end use, hospitals segment is dominated the end use segments with the largest market share of 39.5% in 2023. This is attributable to advanced imaging technologies in hospitals that enable the early detection of retinal disorders, allowing for prompt intervention and treatment. In addition, partnerships & collaborations between hospitals and other companies to meet clinical needs contribute to market growth.

• North America dominated the global market due to the attributed to the well-established healthcare sector, commitment to innovation, advanced infrastructure, a strong emphasis on R&D, the high prevalence of retinal disorders, and rapid adoption of innovative technologies

• Asia Pacific region is expected to witness fastest growth with a CAGR of 8.6% over the forecast period from 2024 to 2030, due to presence of manufacturers with innovative devices manufacturing capabilities coupled with accelerated diagnostic research capabilities.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Device
1.2.2. Application
1.2.3. Indications
1.2.4. End Use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Device outlook
2.2.2. Application outlook
2.2.3. Indications outlook
2.2.4. End use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Retinal Imaging Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of retinal disorders
3.2.1.2. Technological advancements
3.2.1.3. Surge in the geriatric population
3.2.2. Market restraint analysis
3.2.2.1. Shortage of skilled professionals
3.2.2.2. Regulatory challenges
3.3. Retinal Imaging Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Retinal Imaging Devices Market: Device Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Retinal Imaging Devices Device Market Movement Analysis
4.3. Global Retinal Imaging Devices Market Size & Trend Analysis, by Device, 2018 to 2030 (USD Million)
4.4. Optical Coherence Tomography (OCT) Devices
4.4.1. Optical Coherence Tomography (OCT) Devices market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Spectral-Domain OCT (SD-OCT)
4.4.2.1. Spectral-Domain OCT (SD-OCT) market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Swept-Source OCT (SS-OCT)
4.4.3.1. Swept-Source OCT (SS-OCT) market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Handheld OCT
4.4.4.1. Handheld OCT market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Fluorescein Angiography Devices
4.5.1. Fluorescein angiography devices market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Fundus Cameras
4.6.1. Fundus Cameras market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Mydriatic Fundus Cameras
4.6.2.1. Mydriatic fundus cameras market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Non-Mydriatic Fundus Cameras
4.6.3.1. Non-Mydriatic fundus cameras market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Hybrid Fundus Cameras
4.6.4.1. Hybrid fundus cameras market estimates and forecasts 2018 to 2030 (USD Million)
4.6.5. ROP Fundus Cameras
4.6.5.1. ROP fundus cameras market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Retinal Ultrasound Imaging Systems
4.7.1. Retinal ultrasound imaging systems market estimates and forecasts 2018 to 2030 (USD Million)
4.7.2. Ophthalmic A-Scan Ultrasound
4.7.2.1. Ophthalmic A-Scan ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
4.7.3. Ophthalmic B-Scan Ultrasound
4.7.3.1. Ophthalmic B-Scan ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
4.7.4. Ophthalmic Ultrasound Biomicroscopes
4.7.4.1. Ophthalmic ultrasound biomicroscopes market estimates and forecasts 2018 to 2030 (USD Million)
4.7.5. Ophthalmic Pachymeters
4.7.5.1. Ophthalmic pachymeters market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Ultra widefield Retinal Imaging Devices
4.8.1. Retinal ultrasound imaging systems market estimates and forecasts 2018 to 2030 (USD Million
4.9. Widefield Retinal Imaging Devices
4.9.1. Widefield retinal imaging devices market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Retinal Imaging Devices Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Retinal Imaging Devices Application Market Movement Analysis
5.3. Global Retinal Imaging Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Disease Diagnosis
5.4.1. Disease diagnosis market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Treatment Monitoring
5.5.1. Treatment monitoring market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Research and Development
5.6.1. Research and development market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Retinal Imaging Devices Market: Indications Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Retinal Imaging Devices Indications Market Movement Analysis
6.3. Global Retinal Imaging Devices Market Size & Trend Analysis, by Indications, 2018 to 2030 (USD Million)
6.4. Diabetic Retinopathy
6.4.1. Diabetic retinopathy market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Age-Related Macular Degeneration (AMD)
6.5.1. Age-Related Macular Degeneration (AMD) market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Glaucoma
6.6.1. Glaucoma market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Retinal Vein Occlusion
6.7.1. Retinal vein occlusion market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Other Indications
6.8.1. Other indications market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Retinal Imaging Devices Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Retinal Imaging Devices End Use Market Movement Analysis
7.3. Global Retinal Imaging Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Hospitals
7.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Ophthalmology Clinics
7.5.1. Ophthalmology clinics market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Ambulatory Surgery Centers
7.6.1. Ambulatory surgery centers market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Others
7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Retinal Imaging Devices Market: Regional Estimates & Trend Analysis By Device, Application, Indications, End Use
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
8.5. North America
8.5.1. U.S.
8.5.1.1. Key country dynamics
8.5.1.2. Competitive scenario
8.5.1.3. Regulatory framework
8.5.1.4. Reimbursement structure
8.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Reimbursement structure
8.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. Reimbursement structure
8.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key country dynamics
8.6.1.2. Competitive scenario
8.6.1.3. Regulatory framework
8.6.1.4. Reimbursement structure
8.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. Reimbursement structure
8.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. France
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. Reimbursement structure
8.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Italy
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory framework
8.6.4.4. Reimbursement structure
8.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Spain
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory framework
8.6.5.4. Reimbursement structure
8.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Norway
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Regulatory framework
8.6.6.4. Reimbursement structure
8.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Key country dynamics
8.6.7.2. Competitive scenario
8.6.7.3. Regulatory framework
8.6.7.4. Reimbursement structure
8.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Denmark
8.6.8.1. Key country dynamics
8.6.8.2. Competitive scenario
8.6.8.3. Regulatory framework
8.6.8.4. Reimbursement structure
8.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Competitive scenario
8.7.1.3. Regulatory framework
8.7.1.4. Reimbursement structure
8.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. China
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Reimbursement structure
8.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. India
8.7.3.1. Key country dynamics
8.7.3.2. Competitive scenario
8.7.3.3. Regulatory framework
8.7.3.4. Reimbursement structure
8.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Australia
8.7.4.1. Key country dynamics
8.7.4.2. Competitive scenario
8.7.4.3. Regulatory framework
8.7.4.4. Reimbursement structure
8.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. South Korea
8.7.5.1. Key country dynamics
8.7.5.2. Competitive scenario
8.7.5.3. Regulatory framework
8.7.5.4. Reimbursement structure
8.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Competitive scenario
8.7.6.3. Regulatory framework
8.7.6.4. Reimbursement structure
8.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Competitive scenario
8.8.1.3. Regulatory framework
8.8.1.4. Reimbursement structure
8.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Argentina
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Regulatory framework
8.8.2.4. Reimbursement structure
8.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Competitive scenario
8.9.1.3. Regulatory framework
8.9.1.4. Reimbursement structure
8.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Competitive scenario
8.9.2.3. Regulatory framework
8.9.2.4. Reimbursement structure
8.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Competitive scenario
8.9.3.3. Regulatory framework
8.9.3.4. Reimbursement structure
8.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Competitive scenario
8.9.4.3. Regulatory framework
8.9.4.4. Reimbursement structure
8.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Key company market share analysis, 2023
9.4. Company Position Analysis
9.5. Company Categorization (Emerging Players, Innovators and Leaders
9.6. Company Profiles
9.6.1. Carl Zeiss Meditec AG
9.6.1.1. Company overview
9.6.1.2. Financial performance
9.6.1.3. Product benchmarking
9.6.1.4. Strategic initiatives
9.6.2. Topcon Corporation
9.6.2.1. Company overview
9.6.2.2. Financial performance
9.6.2.3. Product benchmarking
9.6.2.4. Strategic initiatives
9.6.3. NIDEK CO., LTD.
9.6.3.1. Company overview
9.6.3.2. Financial performance
9.6.3.3. Product benchmarking
9.6.3.4. Strategic initiatives
9.6.4. Optos
9.6.4.1. Company overview
9.6.4.2. Financial performance
9.6.4.3. Product benchmarking
9.6.4.4. Strategic initiatives
9.6.5. Canon Medical Systems
9.6.5.1. Company overview
9.6.5.2. Financial performance
9.6.5.3. Product benchmarking
9.6.5.4. Strategic initiatives
9.6.6. Essilor Instruments
9.6.6.1. Company overview
9.6.6.2. Financial performance
9.6.6.3. Product benchmarking
9.6.6.4. Strategic initiatives
9.6.7. Optomed
9.6.7.1. Company overview
9.6.7.2. Financial performance
9.6.7.3. Product benchmarking
9.6.7.4. Strategic initiatives
9.6.8. Lumibird Medical
9.6.8.1. Company overview
9.6.8.2. Financial performance
9.6.8.3. Product benchmarking
9.6.8.4. Strategic initiatives
9.6.9. Heidelberg Engineering Inc.
9.6.9.1. Company overview
9.6.9.2. Financial performance
9.6.9.3. Product benchmarking
9.6.9.4. Strategic initiatives
9.6.10. Visionix
9.6.10.1. Company overview
9.6.10.2. Financial performance
9.6.10.3. Product benchmarking
9.6.10.4. Strategic initiatives
9.6.11. OPTOPOL Technology Sp
9.6.11.1. Company overview
9.6.11.2. Financial performance
9.6.11.3. Product benchmarking
9.6.11.4. Strategic initiatives